• |
Net sales increased 10.9 percent to a first quarter record of $188.4 million.
|
• |
Gross profit increased 16.3 percent to a first quarter record of $33.9 million.
|
• |
Operating income increased to $20.1 million from an operating loss of $6.5 million in the prior year.
|
• |
Generated $10.0 million of cash from operating activities and reduced net bank debt by $7.0 million to $74.4 million.
|
• |
Repurchased 197,796 shares for $2.0 million at an average price of $9.94.
|
|
Three Months Ended
|
|||||||
|
June 30,
|
|||||||
|
2025
|
2024
|
||||||
|
||||||||
Net sales
|
$
|
188,364,000
|
$
|
169,887,000
|
||||
Cost of goods sold
|
154,447,000
|
140,713,000
|
||||||
Gross profit
|
33,917,000
|
29,174,000
|
||||||
Operating expenses:
|
||||||||
General and administrative
|
12,680,000
|
16,670,000
|
||||||
Sales and marketing
|
6,210,000
|
5,449,000
|
||||||
Research and development
|
3,306,000
|
2,433,000
|
||||||
Foreign exchange impact of lease liabilities and forward contracts
|
(8,348,000
|
)
|
11,078,000
|
|||||
Total operating expenses
|
13,848,000
|
35,630,000
|
||||||
Operating income (loss)
|
20,069,000
|
(6,456,000
|
)
|
|||||
Other expenses:
|
||||||||
Interest expense, net
|
12,812,000
|
14,387,000
|
||||||
Change in fair value of compound net derivative liability
|
1,790,000
|
(2,580,000
|
)
|
|||||
Total other expenses
|
14,602,000
|
11,807,000
|
||||||
Income (loss) before income tax expense (benefit)
|
5,467,000
|
(18,263,000
|
)
|
|||||
Income tax expense (benefit)
|
2,425,000
|
(178,000
|
)
|
|||||
Net income (loss)
|
$
|
3,042,000
|
$
|
(18,085,000
|
)
|
|||
Basic net income (loss) per share
|
$
|
0.16
|
$
|
(0.92
|
)
|
|||
Diluted net income (loss) per share
|
$
|
0.15
|
$
|
(0.92
|
)
|
|||
Weighted average number of shares outstanding:
|
||||||||
Basic
|
19,369,060
|
19,674,539
|
||||||
Diluted
|
19,917,663
|
19,674,539
|
|
June 30, 2025
|
March 31, 2025
|
||||||
ASSETS
|
(Unaudited)
|
|||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 12,479,000 |
$
|
9,429,000
|
||||
Short-term investments
|
2,011,000 |
1,881,000
|
||||||
Accounts receivable —net
|
85,532,000 |
91,064,000
|
||||||
Inventory — net
|
366,772,000 |
359,669,000
|
||||||
Contract assets
|
30,329,000 |
29,606,000
|
||||||
Prepaid expenses and other current assets
|
22,259,000 |
19,822,000
|
||||||
Total current assets
|
519,382,000 |
511,471,000 | ||||||
Plant and equipment — net
|
33,194,000 | 31,990,000 | ||||||
Operating lease assets
|
68,281,000 | 66,603,000 | ||||||
Long-term deferred income taxes
|
5,504,000 | 4,569,000 | ||||||
Long-term contract assets
|
340,529,000 | 336,268,000 | ||||||
Goodwill and intangible assets — net
|
3,693,000 | 3,757,000 | ||||||
Other assets
|
2,767,000 | 2,978,000 | ||||||
TOTAL ASSETS
|
$
|
973,350,000
|
$ | 957,636,000 | ||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable and accrued liabilities
|
$
|
176,269,000
|
$
|
172,117,000
|
||||
Customer finished goods returns accrual
|
32,926,000
|
34,411,000
|
||||||
Contract liabilities
|
49,396,000
|
38,158,000
|
||||||
Revolving loan
|
86,856,000
|
90,787,000
|
||||||
Other current liabilities
|
4,973,000
|
5,570,000
|
||||||
Operating lease liabilities
|
10,196,000
|
9,982,000
|
||||||
Total current liabilities
|
360,616,000
|
351,025,000
|
||||||
Convertible notes, related party
|
40,844,000
|
35,207,000
|
||||||
Long-term contract liabilities
|
240,021,000
|
241,404,000
|
||||||
Long-term deferred income taxes
|
488,000
|
362,000
|
||||||
Long-term operating lease liabilities
|
63,056,000
|
65,308,000
|
||||||
Other liabilities
|
8,212,000
|
6,631,000
|
||||||
Total liabilities
|
713,237,000
|
699,937,000
|
||||||
Commitments and contingencies
|
||||||||
Shareholders' equity:
|
||||||||
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued Series A junior participating
preferred stock; par value $.01 per share,
|
-
|
-
|
||||||
20,000 shares authorized; none issued
|
-
|
-
|
||||||
Common stock; par value $.01 per share, 50,000,000 shares authorized; 19,352,135 and 19,435,706 shares issued and outstanding at June 30, 2025 and March 31, 2025,
respectively
|
194,000
|
194,000
|
||||||
Additional paid-in capital
|
232,897,000
|
234,413,000
|
||||||
Retained earnings
|
23,075,000
|
20,033,000
|
||||||
Accumulated other comprehensive income
|
3,947,000
|
3,059,000
|
||||||
Total shareholders' equity
|
260,113,000
|
257,699,000
|
||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
973,350,000
|
$
|
957,636,000
|
Items Impacting Net Income for the Three Months Ended June 30, 2025 and 2024 | Exhibit 1 |
Three Months Ended June 30,
|
||||||||||||||||
2025
|
2024
|
|||||||||||||||
|
$ |
Per Diluted
Share
|
|
$ |
Per Diluted
Share
|
|||||||||||
GAAP net income (loss)
|
$
|
3,042,000
|
$
|
0.15
|
$
|
(18,085,000
|
)
|
$
|
(0.92
|
)
|
||||||
Non-cash items impacting net income
|
||||||||||||||||
Core and finished goods premium amortization
|
$
|
2,847,000
|
$
|
0.14
|
$
|
2,728,000
|
$
|
0.14
|
||||||||
Revaluation - cores on customers' shelves
|
1,026,000
|
0.05
|
394,000
|
0.02
|
||||||||||||
Share-based compensation expenses
|
946,000
|
0.05
|
1,000,000
|
0.05
|
||||||||||||
Foreign exchange impact of lease liabilities and forward contracts
|
(8,348,000
|
)
|
(0.42
|
)
|
11,078,000
|
0.56
|
||||||||||
Change in fair value of compound net derivative liability
|
1,790,000
|
0.09
|
(2,580,000
|
)
|
(0.13
|
)
|
||||||||||
Tax effect (a)
|
435,000
|
0.02
|
(3,155,000
|
)
|
(0.16
|
)
|
||||||||||
Total non-cash items impacting net income
|
$
|
(1,304,000
|
)
|
$
|
(0.07
|
)
|
$
|
9,465,000
|
$
|
0.48
|
||||||
Cash items impacting net income
|
||||||||||||||||
New product line start-up costs and transition expenses, and severance and other (b)
|
-
|
-
|
2,940,000
|
0.15
|
||||||||||||
Net tariff costs paid for products sold before price increases were effective
|
1,426,000
|
0.07
|
-
|
-
|
||||||||||||
Tax effect (a)
|
(357,000
|
)
|
(0.02
|
)
|
(735,000
|
)
|
(0.04
|
)
|
||||||||
Total cash items impacting net income
|
$
|
1,069,000
|
$
|
0.05
|
$
|
2,205,000
|
$
|
0.11
|
Items Impacting Gross Profit for the Three Months Ended June 30, 2025 and 2024 | Exhibit 2 |
Three Months Ended June 30,
|
||||||||||||||||
2025
|
2024
|
|||||||||||||||
|
$ |
Gross
Margin
|
|
$ |
Gross
Margin
|
|||||||||||
GAAP gross profit
|
$
|
33,917,000
|
18.0
|
%
|
$
|
29,174,000
|
17.2
|
%
|
||||||||
Non-cash items impacting gross profit
|
||||||||||||||||
Core and finished goods premium amortization
|
$
|
2,847,000
|
1.5
|
%
|
$
|
2,728,000
|
1.6
|
%
|
||||||||
Revaluation - cores on customers' shelves
|
1,026,000
|
0.5
|
%
|
394,000
|
0.2
|
%
|
||||||||||
Total non-cash items impacting gross profit
|
$
|
3,873,000
|
2.1
|
%
|
$
|
3,122,000
|
1.8
|
%
|
||||||||
Cash items impacting gross profit
|
||||||||||||||||
Net tariff costs paid for products sold before price increases were effective
|
1,426,000
|
0.8
|
%
|
-
|
-
|
|||||||||||
Total cash items impacting gross profit
|
$
|
1,426,000
|
0.8
|
%
|
$
|
-
|
0.0
|
%
|
Items Impacting EBITDA for the Three Months Ended June 30, 2025 and 2024 |
Exhibit 3 |
Three Months Ended June 30,
|
||||||||
2025
|
2024
|
|||||||
GAAP net income (loss)
|
$
|
3,042,000
|
$
|
(18,085,000
|
)
|
|||
Interest expense, net
|
12,812,000
|
14,387,000
|
||||||
Income tax expense (benefit)
|
2,425,000
|
(178,000
|
)
|
|||||
Depreciation and amortization
|
2,449,000
|
2,729,000
|
||||||
EBITDA
|
$
|
20,728,000
|
$
|
(1,147,000
|
)
|
|||
Non-cash items impacting EBITDA
|
||||||||
Core and finished goods premium amortization
|
$
|
2,847,000
|
$
|
2,728,000
|
||||
Revaluation - cores on customers' shelves
|
1,026,000
|
394,000
|
||||||
Share-based compensation expenses
|
946,000
|
1,000,000
|
||||||
Foreign exchange impact of lease liabilities and forward contracts
|
(8,348,000
|
)
|
11,078,000
|
|||||
Change in fair value of compound net derivative liability
|
1,790,000
|
(2,580,000
|
)
|
|||||
Total non-cash items impacting EBITDA
|
$
|
(1,739,000
|
)
|
$
|
12,620,000
|
|||
Cash items impacting EBITDA
|
||||||||
New product line start-up costs and transition expenses, and severance and other
|
-
|
2,940,000
|
||||||
Net tariff costs paid for products sold before price increases were effective
|
1,426,000
|
-
|
||||||
Total cash items impacting EBITDA
|
$
|
1,426,000
|
$
|
2,940,000
|